● Recruiting

Virtual Reality Versus Intravenous Dexmedetomidine on Maternal Anxiety, Stress, Hemodynamics, and Neonatal Outcomes During Cesarean Section

Condition: Virtual Reality · Dexmedetomidine · Maternal Anxiety · Sponsor: Benha University

PhaseNA

Planned participants52

Who can joinFemale, 18 Years to no upper limit

Healthy volunteersNo

About this study

This study aims to compare the efficacy of intravenous dexmedetomidine infusion versus virtual reality (VR) in reducing maternal anxiety, stress, and hemodynamic instability during cesarean section and their effects on neonatal outcome as respiration and heart rate.

This description comes directly from the study's public registry record.

Talk to the study team

Emad M Sayed, MBBCH · 00201111710428 · dr.emad.mohamedsayed@gmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

Benha University

Banhā, Benha, Egypt

Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07343843